(Reuters) - BioDelivery Sciences International Inc said it had received U.S. regulatory approval for its drug, Bunavail, to treat opioid dependence. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/koGxkQjhSZQ/story01.htm
Read More
No comments:
Post a Comment